Zhukov v. AstraZeneca plc et al

Track this case

Case overview

Case Number:

1:21-cv-00825

Court:

New York Southern

Nature of Suit:

Securities/Commodities

Multi Party Litigation:

Class Action

Judge:

J. Paul Oetken

Firms

Companies

Sectors & Industries:

  1. September 12, 2022

    AstraZeneca Beats Investors' COVID Vaccine Suit For Good

    A New York federal judge on Monday permanently dismissed a proposed class action alleging AstraZeneca misled investors about the progress of clinical trials for its COVID-19 vaccine, finding the investors didn't identify any misleading statement from the company or show fraudulent intent.

  2. April 30, 2021

    Robbins Geller, Pomerantz To Lead AstraZeneca Investor Suit

    Robbins Geller Rudman & Dowd LLP and Pomerantz LLP have been tapped to represent AstraZeneca investors in a Manhattan federal court suit alleging the company withheld information about problems in the clinical trial of its COVID-19 vaccine.

  3. January 29, 2021

    AstraZeneca Hit With Investor Suit Over COVID-19 Vaccine

    An AstraZeneca investor filed a putative class action in New York federal court Friday accusing the biopharmaceutical giant of withholding information about its COVID-19 vaccine candidate, misleading the public about the progress and adequacy of its clinical trial.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!